Allergy Treatment Market Analysis - Global Industry Size, Share, Trends and Forecast, 2014 - 2024

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Forthcoming | Report ID : ARC217

Heightened sensitivity of the immune system in the body is an allergy. Allergy generally occurs when any harmless foreign substances reacts with the immune system of the body. These harmless foreign substances are known as allergens. Various types of allergens that normally affect the immune system include dust mite, cockroach, animal dander, mold and pollens. As per the World Allergy Organization, approximately 30% to 40% population across the globe was affected by allergic conditions in 2011. Severe allergy such as allergic asthma can reduce the working function of an organ and can be life threatening problem in case of some patients. The rising problem of allergy across the globe is anticipated to create a better opportunity for the allergy treatment market during the forecast period.
For the purpose of in-depth research, the global allergy treatment market can be categorized on the basis of allergy type, treatment type, end user and geography. Various types of allergy problems include eye allergy, rhinitis, asthma and skin allergy among others. On the basis of treatment type, the market can be categorized into anti-allergy medicine and immunotherapy. The anti-allergy medicine can be further bifurcated into antihistamines, corticosteroids, decongestants, mast cell stabilizers and others. The others segment include leukotriene, calcineurin, cromoglicate and anti-lgE. Different categories of allergy treatment methods are used across various end user segments such as hospitals, clinics, medical store, home and others. Based on different geographies, the market is classified into Asia-Pacific, North America, Europe, Middle-East and Africa (MEA) and Latin America. 
Globally, increasing number of population suffering from various types of allergies is the prime aspect forecasted to enhance the demand for various allergy treatment processes during the forecast period. Moreover, increasing environmental pollution is attributing to the growth of allergy problems across various regions. This, in turn, is anticipated to accelerate the growth of allergy treatment process in the coming years. In addition, change in food habits, increasing demand for advanced allergy treatment therapy and rising investment in research and development activities to introduce advance treatment into the market are some of the major factors expected to drive the market for allergy treatment at an exponential rate in the coming years. On the other hand, huge cost required in immunotherapy for treatment of allergy along with various side effects associated with immunotherapy and anti-allergy medicine are some of the major factors anticipated to deter the growth of allergy treatment market during the forecast period. 
Geographically, Europe held the largest market share in terms of revenue in respect of allergy treatment market. Rising number of patients affected with different type of allergies such as respiratory allergy, eye allergy and skin allergy among others coupled with rapid development of healthcare infrastructure along with increasing demand for immunotherapy are the primary factors responsible behind this region’s dominance. The allergy treatment market of Europe is followed by North America. However, Asia-Pacific region is expected to emerge as a promising market in coming years owing to rising awareness towards technologically advanced immunotherapy treatment in line up with rising disposable income and increasing health consciousness among the consumers. Furthermore, increasing investment from governments for rapid development of health care sector in this region is also predicted to drive the market for allergy treatment in Asia-Pacific.
Increasing alliances among the key players operating in the allergy treatment market is another major factor augmenting the growth of allergy treatment market across the globe. Allergy Therapeutics, a leading pharmaceutical company in the U.K, acquired a Spanish company named Alerpharma S.A. in 2015 in order to expand their immunotherapy product portfolio. In the same year, Pfizer Inc. and Allergan plc merged for expanding their market share in the drug industry. Some of the key players operating in the allergy treatment market include, Allergy Therapeutics, Alerpharma S.A, Genentech Inc., Allergopharma GmbH & Co. KG and McNeil Consumer Healthcare among others.

Cart Summary